XOMA Royalty’s Post

View organization page for XOMA Royalty, graphic

5,119 followers

Yesterday we announced we have received an $8.1 million payment from Day One Biopharmaceuticals sale of its Priority Review Voucher (PRV).  Owen Hughes said, “With this milestone in hand, we have more than recouped our initial outlay. And importantly, we anticipate future royalties on OJEMDA™ (tovorafenib) will contribute to a growing portfolio of royalty receipts that will help us drive sustainable free cash flow generation over time.” Our press release can be accessed here https://bit.ly/3KIJpO2   #Milestone #MilestonePayment #Royalty #Royalties #PRV #PriorityReviewVoucher #OJEMDA#tovorafenib #cashflow #DAWN

  • No alternative text description for this image
Dermot Hanley

Non Executive Director (INED) and board member

4mo

Congratulations Brad.

Like
Reply

To view or add a comment, sign in

Explore topics